An APN-activated NIR photosensitizer for cancer photodynamic therapy and fluorescence imaging
Xiao Zhou,Haidong Li,Chao Shi,Feng Xu,Zhen Zhang,Qichao Yao,He Ma,Wen Sun,Kun Shao,Jianjun Du,Saran Long,Jiangli Fan,Jingyun Wang,Xiaojun Peng
DOI: https://doi.org/10.1016/j.biomaterials.2020.120089
IF: 14
2020-09-01
Biomaterials
Abstract:<p>Photodynamic therapy has been developed as a prospective cancer treatment in recent years. Nevertheless, conventional photosensitizers suffer from lacking recognition and specificity to tumors, which causing severe side effects to normal tissues, while the enzyme-activated photosensitizers are capable of solving these conundrums due to high selectivity towards tumors. APN (Aminopeptidase N, APN/CD13), a tumor marker, has become a crucial targeting substance owing to its highly expressed on the cell membrane surface in various tumors, which has become a key point in the research of anti-tumor drug and fluorescence probe. Based on it, herein an APN-activated near-infrared (NIR) photosensitizer (<strong>APN-CyI</strong>) for tumor imaging and photodynamic therapy has been firstly developed and successfully applied <em>in vitro</em> and <em>in vivo</em>. Studies showed that <strong>APN-CyI</strong> could be activated by APN in tumor cells, hydrolyzed to fluorescent <strong>CyI-OH</strong>, which specifically located in mitochondria in cancer cells and exhibited a high singlet oxygen yield under NIR irradiation, and efficiently induced cancer cell apoptosis. Dramatically, the <em>in vivo</em> assays on Balb/c mice showed that <strong>APN-CyI</strong> could achieve NIR fluorescence imaging (λ<sub>em</sub> = 717 nm) for endogenous APN in tumors and possessed an efficient tumor suppression effect under NIR irradiation.</p>
engineering, biomedical,materials science, biomaterials